Le Lézard
Classified in: Health, Science and technology
Subjects: Photo/Multimedia, Product/Service

Axion BioSystems Adds Affordable Maestro Volttm to its Industry-Leading MEA System Lineup


Axion BioSystems today announced the launch of the new Maestro Volttm, an affordable benchtop microelectrode array (MEA) system designed to meet the demands of academic labs with lower throughput needs and limited budgets. Featuring the same ease of use, high-quality controls, and intuitive software synonymous with the Maestro name, the 6-well Maestro Volt is available for both neurological and cardiovascular research applications. The new device expands Axion's flagship Maestro product line and promises to drive scientific discovery by making MEA technology more broadly available.

"Since its founding in 2008, Axion's goal has been to make MEA tools more accessible to scientists studying electrically active cells like neurons and cardiomyocytes. It is gratifying to see how Maestro MEA is increasingly being used in groundbreaking disease research and therapeutic development for Alzheimer's disease, Parkinson's disease, epilepsy, glioblastoma, and others?but budget limitations have put the technology out of reach for some," said Julien Bradley, Chief Executive Officer at Axion BioSystems. "With the addition of the affordable Maestro Volt to our industry-leading product suite, we hope to put the power of Maestro MEA in every lab."

Accurately evaluating electrically active cells in vitro over time is essential in neurological and cardiovascular research. Axion BioSystems' next-generation Maestro MEA platform, which also includes the high-throughput Maestro Protm and the versatile Maestro Edgetm, makes it easy for any scientist to noninvasively measure dynamic electrical activity in 2D and 3D cell models over days, weeks, or months with no labels, dyes, or complicated steps. Using MEA technology, researchers can reveal new insights into the pathogenesis and progression of disease, identify novel druggable targets, explore precision medicine solutions, accelerate regenerative medicine research, and investigate the impact of toxic substances on brain and heart health.

About Axion BioSystems

Axion BioSystems is a leading life sciences tools company focused on innovative live-cell assays used to study the function of cells in vitro for drug discovery and disease modeling. The team at Axion BioSystems is dedicated to continuing the advancement of new technologies that accelerate research and further the understanding of biological complexity outside of the body. Axion BioSystems is headquartered in Atlanta, Georgia, USA, and has offices worldwide. www.axionbiosystems.com


These press releases may also interest you

at 09:37
Asembia Brings Together Top Pharmacy Executives for 20th Summit; Hosting Cornerstone Conference Delivering Continued Collaboration and Connections
Held earlier this month, Asembia's 2024 Specialty Pharmacy Summit, AXS24, eclipsed another record attendance, further establishing the conference's role as a top convener of industry leaders who come together to discuss the latest and best ways to...

at 09:36
Ministerial Statement on the International Day Against Homophobia, Transphobia, and Biphobia
The Honourable Marci Ien, Minister for Women and Gender Equality and Youth, the Honourable Mark Holland, Minister of Health, and the Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, issued the...

at 09:32
Do Beauty Influencers Impact Gen Z's Mental Health? Beekman 1802, Kindness.org & Traackr uncover the scientific link between Mental Health and Kindness on Digital Platforms
Gen Z is looking at influencers' values as much as they are looking at their product recommendations, in fact over 60% feel that influencers' posts have some impact on their decisions made in their everyday lives. Influencers' values, including...

at 09:30
Government of Canada supports development & point-of-care dissemination of national antimicrobial prescribing guidelines
In Canada and across the world, microbes that cause infections are becoming increasingly resistant to the drugs designed to treat them - this is known as antimicrobial resistance (AMR). While AMR can happen naturally, the misuse and overuse of...

at 09:30
During Mental Health Awareness Month, Scholastic Launches Resources to Make the Benefits of Literacy for Children's Emotional Well-Being More Accessible
Scholastic, the global children's publishing, education and media company, has launched an online hub of books and curated, free resources with insights from leading child development experts to encourage positive experiences in and out of the...

at 09:16
The Oxford-Harrington Rare Disease Centre Announces Newly Funded Grant Award Programmes to Develop New Therapies for Friedreich's Ataxia
The Oxford-Harrington Rare Disease Centre ('OHC'), a partnership (between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio) aimed at driving cutting-edge rare disease breakthroughs, is pleased...

More news about Health...


News published on and distributed by: